On the public citation graph
Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy
0 signed · 135 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ijc.22703openalex-snapshot
Expression of B7‐H1 in breast cancer patients is strongly associated with high proliferative Ki‐67‐expressing tumor cells
inferredcites →https://doi.org/10.1007/s00262-012-1289-2openalex-snapshot
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer
inferredcites →https://doi.org/10.1007/s00262-012-1293-6openalex-snapshot
The expression, function, and clinical relevance of B7 family members in cancer
inferredcites →https://doi.org/10.1007/s12026-011-8227-9openalex-snapshot
T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract
inferredcites →https://doi.org/10.1007/s12032-015-0655-2openalex-snapshot
PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma
inferredcites →https://doi.org/10.1007/s40265-016-0588-xopenalex-snapshot
Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
inferredcites →https://doi.org/10.1016/j.acthis.2006.01.003openalex-snapshot
Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance
inferredcites →https://doi.org/10.1016/j.ccell.2015.08.004openalex-snapshot
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
inferredcites →https://doi.org/10.1016/j.hemonc.2013.09.005openalex-snapshot
The immunoinhibitory B7-H1 molecule as a potential target in cancer
inferredcites →https://doi.org/10.1016/j.it.2013.07.003openalex-snapshot
B7 family checkpoint regulators in immune regulation and disease
inferredcites →https://doi.org/10.1016/j.jtho.2016.04.007openalex-snapshot
Prognostic Significance of PD-L1 in Patients with Non–Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases
inferredcites →https://doi.org/10.1016/s1470-2045(16)30066-3openalex-snapshot
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
inferredcites →https://doi.org/10.1016/s1556-0864(16)30194-0openalex-snapshot
81P Radiation resistance induced immunity evasion by evoking PD-L1 expression
inferredcites →https://doi.org/10.1038/70932openalex-snapshot
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
inferredcites →https://doi.org/10.1038/nature13904openalex-snapshot
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
inferredcites →https://doi.org/10.1038/nature13954openalex-snapshot
PD-1 blockade induces responses by inhibiting adaptive immune resistance
inferredcites →https://doi.org/10.1038/nature14011openalex-snapshot
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
inferredcites →https://doi.org/10.1038/nature15520openalex-snapshot
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
inferredcites →https://doi.org/10.1038/nri2326openalex-snapshot
Inhibitory B7-family molecules in the tumour microenvironment
inferredcites →https://doi.org/10.1056/nejmoa1200694openalex-snapshot
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
inferredcites →https://doi.org/10.1080/2162402x.2015.1091146openalex-snapshot
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage
inferredcites →https://doi.org/10.1093/annonc/mdw216openalex-snapshot
Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches
inferredcites →https://doi.org/10.1093/jnci/djv303openalex-snapshot
PDL1 Regulation by p53 via miR-34
inferredcites →https://doi.org/10.1095/biolreprod.102.010058openalex-snapshot
B7 Family Molecules Are Favorably Positioned at the Human Maternal-Fetal Interface1
inferredcites →https://doi.org/10.1126/scitranslmed.aad7118openalex-snapshot
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
inferredcites →https://doi.org/10.1158/0008-5472.can-10-2217openalex-snapshot
B7-H1 Overexpression Regulates Epithelial–Mesenchymal Transition and Accelerates Carcinogenesis in Skin
inferredcites →https://doi.org/10.1158/0008-5472.can-11-0527openalex-snapshot
Immunoregulatory Molecule B7-H1 (CD274) Contributes to Skin Carcinogenesis
inferredcites →https://doi.org/10.1158/0008-5472.can-15-2001openalex-snapshot
Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-15-1352openalex-snapshot
PD-1 Blockade Boosts Radiofrequency Ablation–Elicited Adaptive Immune Responses against Tumor
inferredcites →https://doi.org/10.1158/1078-0432.ccr-15-1434openalex-snapshot
Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
inferredcites →https://doi.org/10.1158/1078-0432.ccr-15-2665openalex-snapshot
CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell–Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1
inferredcites →https://doi.org/10.1159/000438587openalex-snapshot
Melatonin Induces Cell Apoptosis in AGS Cells Through the Activation of JNK and P38 MAPK and the Suppression of Nuclear Factor-Kappa B: a Novel Therapeutic Implication for Gastric Cancer
inferredcites →https://doi.org/10.1159/000445555openalex-snapshot
Periplocin Extracted from Cortex Periplocae Induced Apoptosis of Gastric Cancer Cells via the ERK1/2-EGR1 Pathway
inferredcites →https://doi.org/10.1186/s12943-015-0421-2openalex-snapshot
Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
inferredcites →https://doi.org/10.1371/journal.pone.0076012openalex-snapshot
B7-H1 Expression Is Associated with Poor Prognosis in Colorectal Carcinoma and Regulates the Proliferation and Invasion of HCT116 Colorectal Cancer Cells
inferredcites →https://doi.org/10.1371/journal.pone.0135528openalex-snapshot
B7H1 Expression and Epithelial-To-Mesenchymal Transition Phenotypes on Colorectal Cancer Stem-Like Cells
inferredcites →https://doi.org/10.1371/journal.pone.0156323openalex-snapshot
Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis
inferredcites →https://doi.org/10.18632/oncotarget.7243openalex-snapshot
Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer
inferredcites →https://doi.org/10.18632/oncotarget.8956openalex-snapshot
Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
inferredcites →https://doi.org/10.2147/ott.s102616openalex-snapshot
Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis
inferredcites →https://doi.org/10.7150/jca.14549openalex-snapshot
PD-L1 Expression Is Associated with Tumor FOXP3+ Regulatory T-Cell Infiltration of Breast Cancer and Poor Prognosis of Patient
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4894921openalex-extracted
Targeting Pd-L1 Combined with Paclitaxel Hampers Gastric Cancer Progression by Modulating Cell Proliferation, Apoptosis, and Migration
inferred← citeshttps://doi.org/10.1002/cbdv.201900189openalex-snapshot
Antiproliferative Activity of Chemically Characterized Propolis from Turkey and Its Mechanisms of Action
inferred← citeshttps://doi.org/10.1002/cbic.202400854openalex-snapshot
Nucleic Acid Drugs in Radiotherapy
inferred← citeshttps://doi.org/10.1002/jcb.26645openalex-snapshot
T cell exhaustion in cancer: Mechanisms and clinical implications
inferred← citeshttps://doi.org/10.1002/jcb.27329openalex-snapshot
LPS promotes the expression of PD‐L1 in gastric cancer cells through NF‐κB activation
inferred← citeshttps://doi.org/10.1007/978-3-030-67951-4_6openalex-snapshot
Epithelial and Immune Cell Responses to Helicobacter pylori That Shape the Gastric Tumor Microenvironment
inferred← citeshttps://doi.org/10.1007/s00262-020-02621-9openalex-snapshot
Infiltration of T cells promotes the metastasis of ovarian cancer cells via the modulation of metastasis-related genes and PD-L1 expression
inferred← citeshttps://doi.org/10.1007/s10120-020-01059-3openalex-snapshot
Epstein–Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas
inferred← citeshttps://doi.org/10.1007/s10238-022-00852-xopenalex-snapshot
Immunohistochemical expression of PD-L1 and MDR1 in breast tumors: association with clinico-pathological parameters and treatment outcome
inferred← citeshttps://doi.org/10.1007/s10620-020-06819-wopenalex-snapshot
HIF1A-AS2 Promotes the Proliferation and Metastasis of Gastric Cancer Cells Through miR-429/PD-L1 Axis
inferred← citeshttps://doi.org/10.1007/s12032-023-01965-3openalex-snapshot
PD-1/PD-L1 blockade inhibits epithelial-mesenchymal transition and improves chemotherapeutic response in breast cancer
inferred← citeshttps://doi.org/10.1007/s12094-021-02743-1openalex-snapshot
STAT1/IFIT2 signaling pathway is involved in PD-L1-mediated epithelial-to-mesenchymal transition in human esophageal cancer
inferred← citeshttps://doi.org/10.1007/s13760-018-0944-6openalex-snapshot
RETRACTED ARTICLE: Yap-Hippo pathway regulates cerebral hypoxia-reoxygenation injury in neuroblastoma N2a cells via inhibiting ROCK1/F-actin/mitochondrial fission pathways
inferred← citeshttps://doi.org/10.1016/j.actbio.2019.08.046openalex-snapshot
Effects of gold nanoprism-assisted human PD-L1 siRNA on both gene down-regulation and photothermal therapy on lung cancer
inferred← citeshttps://doi.org/10.1016/j.ajps.2021.07.004openalex-snapshot
Spatiotemporally co-delivery of triple therapeutic drugs via HA-coating nanosystems for enhanced immunotherapy
inferred← citeshttps://doi.org/10.1016/j.apsb.2021.11.005openalex-snapshot
Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade
inferred← citeshttps://doi.org/10.1016/j.bbadis.2018.03.002openalex-snapshot
PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation
inferred← citeshttps://doi.org/10.1016/j.bcp.2020.114038openalex-snapshot
Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.12.046openalex-snapshot
RETRACTED: INF2 regulates oxidative stress-induced apoptosis in epidermal HaCaT cells by modulating the HIF1 signaling pathway
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.114732openalex-snapshot
Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.cellimm.2021.104469openalex-snapshot
Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer
inferred← citeshttps://doi.org/10.1016/j.celrep.2021.109181openalex-snapshot
PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.103343openalex-snapshot
Successes and failures of immunotherapy for gastric cancer
inferred← citeshttps://doi.org/10.1016/j.intimp.2022.109022openalex-snapshot
A review of PD-1/PD-L1 siRNA delivery systems in immune T cells and cancer cells
inferred← citeshttps://doi.org/10.1016/j.mgene.2018.03.001openalex-snapshot
Differential expression profiles of miRNAs and correlation with clinical outcomes in acute myeloid leukemia
inferred← citeshttps://doi.org/10.1016/j.neo.2018.09.008openalex-snapshot
Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549
inferred← citeshttps://doi.org/10.1016/j.tranon.2018.08.005openalex-snapshot
Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation
inferred← citeshttps://doi.org/10.1016/j.trsl.2020.12.003openalex-snapshot
Tumor-derived extracellular vesicles containing microRNA-1290 promote immune escape of cancer cells through the Grhl2/ZEB1/PD-L1 axis in gastric cancer
inferred← citeshttps://doi.org/10.1038/s41388-018-0347-4openalex-snapshot
Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer
inferred← citeshttps://doi.org/10.1038/s41419-018-0404-5openalex-snapshot
Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer
inferred← citeshttps://doi.org/10.1038/s41419-020-2701-zopenalex-snapshot
PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer
inferred← citeshttps://doi.org/10.1038/s41598-022-15020-0openalex-snapshot
PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway
inferred← citeshttps://doi.org/10.1038/s41598-023-27415-8openalex-snapshot
Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression
inferred← citeshttps://doi.org/10.1053/j.gastro.2020.10.036openalex-snapshot
PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in Mice
inferred← citeshttps://doi.org/10.1080/08923973.2021.1936013openalex-snapshot
Protective role of astragaloside IV in gastric cancer through regulation of microRNA-195-5p-mediated PD-L1
inferred← citeshttps://doi.org/10.1080/10717544.2021.1931560openalex-snapshot
A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids
inferred← citeshttps://doi.org/10.1080/21655979.2021.2001216openalex-snapshot
MicroRNA-506 has a suppressive effect on the tumorigenesis of nonsmall-cell lung cancer by regulating tubby-like protein 3
inferred← citeshttps://doi.org/10.1111/1440-1681.13056openalex-snapshot
Undo the brake of tumour immune tolerance with antibodies, peptide mimetics and small molecule compounds targeting PD‐1/PD‐L1 checkpoint at different locations for acceleration of cytotoxic immunity to cancer cells
inferred← citeshttps://doi.org/10.1136/jitc-2023-007171openalex-snapshot
RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment
inferred← citeshttps://doi.org/10.1159/000480000openalex-snapshot
PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer
inferred← citeshttps://doi.org/10.1159/000488634openalex-snapshot
MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLC
inferred← citeshttps://doi.org/10.1159/000495896openalex-snapshot
Mammalian STE20-Like Kinase 1 Deletion Alleviates Renal Ischaemia-Reperfusion Injury via Modulating Mitophagy and the AMPK-YAP Signalling Pathway
inferred← citeshttps://doi.org/10.1159/000509033openalex-snapshot
Role of PD-L1 Expression during the Progression of Submucosal Gastric Cancer
inferred← citeshttps://doi.org/10.1177/0300891620949668openalex-snapshot
Overview on new progress of hereditary diffuse gastric cancer with CDH1 variants
inferred← citeshttps://doi.org/10.1177/1010428317714626openalex-snapshot
Progress in the treatment of advanced gastric cancer
inferred← citeshttps://doi.org/10.1177/1724600819876951openalex-snapshot
High expression of IQGAP3 indicates poor prognosis in colorectal cancer patients
inferred← citeshttps://doi.org/10.1182/blood.2021012811openalex-snapshot
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma
inferred← citeshttps://doi.org/10.1186/s11658-018-0085-1openalex-snapshot
Mst1 regulates post-infarction cardiac injury through the JNK-Drp1-mitochondrial fission pathway
inferred← citeshttps://doi.org/10.1186/s12885-021-09062-2openalex-snapshot
A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer
inferred← citeshttps://doi.org/10.1186/s12935-018-0615-yopenalex-snapshot
RETRACTED ARTICLE: TAZ inhibition promotes IL-2-induced apoptosis of hepatocellular carcinoma cells by activating the JNK/F-actin/mitochondrial fission pathway
inferred← citeshttps://doi.org/10.1186/s12935-019-0824-zopenalex-snapshot
Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients
inferred← citeshttps://doi.org/10.1186/s12935-020-01479-2openalex-snapshot
miR-502-5p affects gastric cancer progression by targeting PD-L1
inferred← citeshttps://doi.org/10.1186/s12935-021-02287-yopenalex-snapshot
Increased expression of TAZ and associated upregulation of PD-L1 in cervical cancer
inferred← citeshttps://doi.org/10.1186/s12935-024-03554-4openalex-snapshot
High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype
inferred← citeshttps://doi.org/10.1186/s13000-020-00979-zopenalex-snapshot
Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas
inferred← citeshttps://doi.org/10.1186/s13045-018-0589-1openalex-snapshot
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
inferred← citeshttps://doi.org/10.1186/s13046-019-1496-1openalex-snapshot
Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway
inferred← citeshttps://doi.org/10.1371/journal.pone.0206818openalex-snapshot
Cancer immunotherapy using PolyPurine Reverse Hoogsteen hairpins targeting the PD-1/PD-L1 pathway in human tumor cells
inferred← citeshttps://doi.org/10.1371/journal.ppat.1007468openalex-snapshot
Increased Programmed Death-Ligand 1 is an Early Epithelial Cell Response to Helicobacter pylori Infection
inferred← citeshttps://doi.org/10.21037/jgo-21-79openalex-snapshot
Adaptive immunity profiling associated with histological subtypes and postoperative survival in gastric cancer
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1248526/v1openalex-snapshot
Immunohistochemical Expression of PD-L1 and MDR1 in Breast Tumors: Association with Clinico-Pathological Parameters and Treatment Outcome
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2744681/v1openalex-snapshot
Application of traditional Chinese medicine in inhibiting the PD-L1 pathway for gastric cancer and colon cancer treatment
inferred← citeshttps://doi.org/10.2147/ijn.s518427openalex-snapshot
Photothermal Therapeutic Gold Nanoparticles Loaded with PD-L1 siRNA Enhanced Killing of NSCLC Cells by Immune Cells
inferred← citeshttps://doi.org/10.2147/ott.s184337openalex-snapshot
TNFα promotes glioblastoma A172 cell mitochondrial apoptosis via augmenting mitochondrial fission and repression of MAPK–ERK–YAP signaling pathways
inferred← citeshttps://doi.org/10.21873/anticanres.14376openalex-snapshot
Cytokine-induced Killer T Cells Enhance the Cytotoxicity Against Carboplatin-resistant Ovarian Cancer Cells
inferred← citeshttps://doi.org/10.2217/nnm-2019-0397openalex-snapshot
Anti-PD-L1-Modified and ATRA-Loaded Nanoparticles for Immuno-Treatment of Oral Dysplasia and Oral Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.30498/ijb.2019.85180openalex-snapshot
Producing Soluble Human Programmed Cell Death Protein-1: A Natural Supporter for CD4+T Cell Cytotoxicity and Tumor Cells Apoptosis.
inferred← citeshttps://doi.org/10.3389/fimmu.2020.568931openalex-snapshot
The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment
inferred← citeshttps://doi.org/10.3389/fimmu.2022.1060497openalex-snapshot
PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1658864openalex-snapshot
Case Report: Three cases with allogeneic CIK therapy against solid tumors
inferred← citeshttps://doi.org/10.3389/fonc.2018.00386openalex-snapshot
Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
inferred← citeshttps://doi.org/10.3389/fonc.2020.00749openalex-snapshot
Prognostic Value of Programmed Cell Death 1 Ligand-1 in Patients With Bone and Soft Tissue Sarcomas: A Systemic and Comprehensive Meta-Analysis Based on 3,680 Patients
inferred← citeshttps://doi.org/10.3389/fonc.2022.992260openalex-snapshot
Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression
inferred← citeshttps://doi.org/10.3389/fphar.2020.00251openalex-snapshot
(-)-Sativan Inhibits Tumor Development and Regulates miR-200c/PD-L1 in Triple Negative Breast Cancer Cells
inferred← citeshttps://doi.org/10.3389/fphar.2021.733075openalex-snapshot
Adaptive NK Cell Therapy Modulated by Anti-PD-1 Antibody in Gastric Cancer Model
inferred← citeshttps://doi.org/10.3390/biom14121581openalex-snapshot
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies
inferred← citeshttps://doi.org/10.3390/cancers11081050openalex-snapshot
PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer
inferred← citeshttps://doi.org/10.3390/cancers12030701openalex-snapshot
A Comparative Analysis of Tumors and Plasma Circulating Tumor DNA in 145 Advanced Cancer Patients Annotated by 3 Core Cellular Processes
inferred← citeshttps://doi.org/10.3390/cancers12082105openalex-snapshot
From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary Perspective
inferred← citeshttps://doi.org/10.3390/cells10040872openalex-snapshot
Depleting Tumor Cells Expressing Immune Checkpoint Ligands—A New Approach to Combat Cancer
inferred← citeshttps://doi.org/10.3390/cimb46090600openalex-snapshot
Disulfidptosis: A New Target for Parkinson’s Disease and Cancer
inferred← citeshttps://doi.org/10.3390/ijms24054478openalex-snapshot
Variable Intrinsic Expression of Immunoregulatory Biomarkers in Breast Cancer Cell Lines, Mammospheres, and Co-Cultures
inferred← citeshttps://doi.org/10.3390/ijms24076420openalex-snapshot
PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression
inferred← citeshttps://doi.org/10.3390/ijms241915016openalex-snapshot
Autophagy as a Target for Non-Immune Intrinsic Functions of Programmed Cell Death-Ligand 1 in Cancer
inferred← citeshttps://doi.org/10.3390/life12020238openalex-snapshot
PD-L1 Expression Correlated with Clinicopathological Factors and Akt/Stat3 Pathway in Oral SCC
inferred← citeshttps://doi.org/10.3727/096504020x15925659763817openalex-snapshot
Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells
inferred← citeshttps://doi.org/10.3892/ijo.2018.4380openalex-snapshot
miR-125a induces apoptosis, metabolism disorder and migrationimpairment in pancreatic cancer cells by targeting Mfn2-related mitochondrial fission
inferred← citeshttps://doi.org/10.3892/ijo.2019.4794openalex-snapshot
Epithelial ovarian cancer stem‑like cells are resistant to the cellular lysis of cytokine‑induced killer cells via HIF1A‑mediated downregulation of ICAM‑1
inferred← citeshttps://doi.org/10.3892/ol.2019.11234openalex-snapshot
MicroRNA‑519 inhibits hypoxia‑induced tumorigenesis of pancreatic cancer by regulating immune checkpoint PD‑L1
inferred← citeshttps://doi.org/10.3892/ol.2020.11828openalex-snapshot
CD8+ T cells located in tertiary lymphoid structures are associated with improved prognosis in patients with gastric cancer
inferred← citeshttps://doi.org/10.3892/ol.2022.13596openalex-snapshot
Research progress on the intrinsic non‑immune function of PD‑L1 in tumors (Review)
inferred← citeshttps://doi.org/10.3923/ijp.2025.259.269openalex-snapshot
PD-L1 Palmitoylation by ZDHHC3 Contributes to Chemoresistance and Inhibits CD8+ T Cell Cytotoxicity in Gastric Cancer
inferred← citeshttps://doi.org/10.4251/wjgo.v12.i11.1346openalex-snapshot
Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis
inferred← citeshttps://doi.org/10.7190/shu-thesis-00520openalex-snapshot
Investigating the Intrinsic Role of Programmed Death-Ligand 1 in Human Cancers.
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.